grant

Toll-like receptor 2 signalling as a potential therapeutic target in gastric cancer [ 2015 - 2021 ]

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1088634]

Researchers: Dr Alison West (Principal investigator)

Brief description Stomach cancer is the fourth most deadly cancer in the world. Stomach cancer is closely linked with inflammation, and we have shown that a key inflammatory molecule, called toll-like receptor 2 (TLR2), can drive the development of stomach cancer. However, this occurs in a non-inflammatory manner. My research aims to understand how TLR2 is involved in the progression of stomach cancer, with the ultimate goal to find an early biomarker of disease, and to develop better therapies.

Funding Amount $AUD 323,091.84

Funding Scheme Early Career Fellowships

Notes Peter Doherty Biomedical ECF

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]
ACN 633 798 857